Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
If you've been Googling "is tirzepatide a peptide" at midnight, you're probably looking for something that actually works
Additional TRIUMPH and Other Phase 3 Trials Lilly has initiated or announced additional Phase 3 trials for retatrutide: Chronic low back pain -- Phase 3 initiated in Q3 2025 Overweight/obesity (additional) -- new Phase 3 trial initiated in Q3 2025 MASLD master protocol (NCT07165028) -- a Phase 3 multi-agent master protocol in MASLD that includes retatrutide (not a dedicated retatrutide-only liver trial), building on the Phase 2 liver fat sub-study TRANSCEND Program -- Type 2 Diabetes TRANSCEND Phase 3 program evaluating retatrutide specifically for type 2 diabetes
It frames the shorter window as a deliberate consequence of USP standards that prioritize sterility and patient-specific preparation over extended stability
Most researchers prefer the first option for simplicity
